Weisdorf, Daniel J.

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

McCarthy, P. L., Owzar, K., Hofmeister, C. C., Hurd, D. D., Hassoun, H., Richardson, P. G., Giralt, S., Stadtmauer, E. A., Weisdorf, D. J., Vij, R., et al. (2012) · New England Journal of Medicine

Multiple Myeloma Research and TreatmentsBone health and treatments

Cited by 1,147

ROCK2 inhibition with belumosudil (KD025) for the treatment of chronic graft-versus-host disease

Jagasia, M., Lazaryan, A., Bachier, C. R., Salhotra, A., Weisdorf, D. J., Zoghi, B., Essell, J., Green, L., Schueller, O., Patel, J., et al. (2021) · Journal of Clinical Oncology

Hematopoietic Stem Cell TransplantationImmunodeficiency and Autoimmune Disorders

Cited by 198

Is the international staging system superior to the Durie–Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant

Hari, P. N., Zhang, M.-J., Roy, V, Pérez, W. S., Bashey, A., To, L. B., Elfenbein, G., Freytes, C. O., Gale, R. P., Gibson, J., et al. (2009) · Leukemia

Multiple Myeloma Research and TreatmentsMultiple Sclerosis Research Studies

Cited by 100

Access to CAR T-cell therapy: Focus on diversity, equity and inclusion

Odstrcil, M. S., Lee, C. J., Sobieski, C., Weisdorf, D., & Couriel, D. (2024) · Blood Reviews

CAR-T cell therapy researchPharmaceutical Economics and Policy

Cited by 50

Antibiotic practice patterns in hematopoietic cell transplantation: A survey of blood and marrow transplant clinical trials network centers

Rashidi, A., Wangjam, T., Bhatt, A. S., Weisdorf, D. J., Holtan, S. G., & on behalf of BMT CTN Investigators (2018) · American Journal of Hematology

Neutropenia and Cancer InfectionsAntibiotic Use and Resistance

Cited by 26